[go: up one dir, main page]

ATE91409T1 - Schnelloesliche dosierungsformen. - Google Patents

Schnelloesliche dosierungsformen.

Info

Publication number
ATE91409T1
ATE91409T1 AT90306632T AT90306632T ATE91409T1 AT E91409 T1 ATE91409 T1 AT E91409T1 AT 90306632 T AT90306632 T AT 90306632T AT 90306632 T AT90306632 T AT 90306632T AT E91409 T1 ATE91409 T1 AT E91409T1
Authority
AT
Austria
Prior art keywords
quick
dosage forms
dissolve dosage
dissolve
pediatric
Prior art date
Application number
AT90306632T
Other languages
English (en)
Inventor
Robert George Blank
Dhiraj Shantilal Mody
Richard John Kenny
Martha Caralyn Aveson
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Application granted granted Critical
Publication of ATE91409T1 publication Critical patent/ATE91409T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT90306632T 1989-06-20 1990-06-19 Schnelloesliche dosierungsformen. ATE91409T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/368,612 US4946684A (en) 1989-06-20 1989-06-20 Fast dissolving dosage forms

Publications (1)

Publication Number Publication Date
ATE91409T1 true ATE91409T1 (de) 1993-07-15

Family

ID=23451975

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90306632T ATE91409T1 (de) 1989-06-20 1990-06-19 Schnelloesliche dosierungsformen.

Country Status (10)

Country Link
US (1) US4946684A (de)
EP (1) EP0404490B1 (de)
AT (1) ATE91409T1 (de)
CA (1) CA2019228A1 (de)
DE (1) DE69002198T2 (de)
DK (1) DK0404490T3 (de)
ES (1) ES2057409T3 (de)
IE (1) IE63834B1 (de)
MX (1) MX21218A (de)
PT (1) PT94395B (de)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5215756A (en) * 1989-12-22 1993-06-01 Gole Dilip J Preparation of pharmaceutical and other matrix systems by solid-state dissolution
DE69331839T2 (de) * 1992-01-29 2002-12-12 Takeda Chemical Industries, Ltd. Schnellösliche Tablette und ihre Herstellung
US5348747A (en) * 1992-03-05 1994-09-20 American Home Products Corporation Pharmaceutical coating sugars
US5298261A (en) * 1992-04-20 1994-03-29 Oregon Freeze Dry, Inc. Rapidly distintegrating tablet
JPH06218028A (ja) * 1992-10-02 1994-08-09 Eisai Co Ltd 湿製錠の成型方法とその装置及び湿製錠
ATE208615T1 (de) * 1993-07-09 2001-11-15 Scherer Corp R P Verfahren zur herstellung von gefriergetrockneten arzneistoffdosierungsformen
US5382437A (en) * 1993-10-25 1995-01-17 Hunter Research Corporation Frozen liquified gas composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs
US5637313A (en) * 1994-12-16 1997-06-10 Watson Laboratories, Inc. Chewable dosage forms
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
DE19652257A1 (de) 1996-12-16 1998-06-18 Lohmann Therapie Syst Lts Einzeln dosierte, bei Kontakt mit Flüssigkeit schnell zerfallende, wirkstoff- und insbesondere aromastoffhaltige, folienförmige Darreichnungsform
US6552024B1 (en) 1999-01-21 2003-04-22 Lavipharm Laboratories Inc. Compositions and methods for mucosal delivery
GB9908014D0 (en) * 1999-04-08 1999-06-02 Scherer Corp R P Pharmaceutical compositions
GB9910505D0 (en) 1999-05-06 1999-07-07 Electrosols Ltd A method and apparatus for manufacturing consumable tablets
DE19931708A1 (de) 1999-07-08 2001-01-18 Bayer Ag Verfahren zur Herstellung schnell zerfallender, fester pharmazeutischer Zubereitungen
IN192750B (de) * 2000-12-15 2004-05-15 Ranbaxy Lab Ltd
CA2435546A1 (en) * 2001-02-08 2002-08-15 Alice C. Martino Rapid-onset medicament for the treatment of sexual dysfunction
EP1372604A2 (de) * 2001-03-22 2004-01-02 Battelle Memorial Institute Herstellungsverfahren von auflösenden dosierungsformen
US6509040B1 (en) * 2001-06-22 2003-01-21 R.P. Scherer Corporation Fast dispersing dosage forms essentially free of mammalian gelatin
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
US20030104017A1 (en) * 2001-10-26 2003-06-05 Boehringer Ingelheim International Gmbh Epinastine formulation for oral administration
US7972632B2 (en) 2003-02-28 2011-07-05 Unigen Pharmaceuticals, Inc. Identification of Free-B-Ring flavonoids as potent COX-2 inhibitors
US7108868B2 (en) 2002-03-22 2006-09-19 Unigen Pharmaceuticals, Inc. Isolation of a dual cox-2 and 5-lipoxygenase inhibitor from acacia
AU2003228777C1 (en) 2002-04-30 2009-08-13 Unigen, Inc. Formulation of a mixture of free-B-ring flavonoids and flavans as a therapeutic agent
US8034387B2 (en) * 2002-04-30 2011-10-11 Unigen, Inc. Formulation of a mixture of free-B-ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairments
US20030215498A1 (en) * 2002-05-17 2003-11-20 Harland Ronald S. Rapidly disintegrating comressed tablets comprising biologically active compounds
US20030017208A1 (en) * 2002-07-19 2003-01-23 Francis Ignatious Electrospun pharmaceutical compositions
US20050043296A1 (en) * 2002-10-04 2005-02-24 Michael Hawley Compositions and methods for treating sexual dysfunction
GB0226076D0 (en) * 2002-11-08 2002-12-18 Rp Scherer Technologies Inc Improved formulations containing substituted imidazole derivatives
US8367111B2 (en) * 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
CA2521429A1 (en) * 2003-04-04 2004-10-21 Unigen Pharmaceuticals, Inc. Formulation of dual cycloxygenase (cox) and lipoxygenase (lox) inhibitors for mammal skin care
US7282217B1 (en) 2003-08-29 2007-10-16 Kv Pharmaceutical Company Rapidly disintegrable tablets
CA2537459A1 (en) * 2003-09-02 2005-03-10 Unigen Pharmaceuticals, Inc. Formulation of a mixture of free-b-ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairments
US8747895B2 (en) 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
EP2417969A1 (de) 2004-10-21 2012-02-15 Aptalis Pharmatech, Inc. Geschmacksverdeckende pharmazeutische Zusammensetzungen mit magenlöslichen Porenbildnern
US20060105038A1 (en) * 2004-11-12 2006-05-18 Eurand Pharmaceuticals Limited Taste-masked pharmaceutical compositions prepared by coacervation
AU2006206252B2 (en) 2005-01-19 2009-11-05 Neurohealing Pharmaceuticals, Inc. Methods and compositions for decreasing saliva production
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
WO2008008120A1 (en) * 2006-07-14 2008-01-17 Fmc Corporation Solid form
US9005652B2 (en) * 2006-07-25 2015-04-14 Wyeth Chewable tablet containing phenylephrine
US20080311162A1 (en) * 2007-05-16 2008-12-18 Olivia Darmuzey Solid form
JP5547096B2 (ja) * 2008-02-28 2014-07-09 アール.ピー. シェーラー テクノロジーズ エルエルシー 多型を最小化する方法
US8980229B2 (en) 2009-04-01 2015-03-17 Colgate-Palmolive Company Dentifrice compositions and methods for treating and preventing damage to tooth surfaces
CN102933207B (zh) 2009-10-30 2018-02-02 Ix生物医药有限公司 快速溶解固体剂型
US12186426B2 (en) 2009-10-30 2025-01-07 Ix Biopharma Ltd. Solid dosage form
TWI471146B (zh) 2009-12-02 2015-02-01 Aptalis Pharma Ltd 菲索特芬那定(fexofenadine)微膠囊及包含其之組合物
WO2011085181A1 (en) * 2010-01-08 2011-07-14 Eurand, Inc. Taste masked topiramate composition and an orally disintegrating tablet comprising the same
US8900557B2 (en) 2010-12-30 2014-12-02 Jr Chem, Llc Dental cleaning composition
US11173098B1 (en) 2016-02-05 2021-11-16 Gram Tactical Llc Magazines for tactical medicine dispensers
US20230172844A1 (en) * 2019-08-12 2023-06-08 Tenshi Kaizen Private Limited Cannabidiol orally disintegrating tablets

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3145146A (en) * 1961-10-31 1964-08-18 Warner Lambert Pharmaceutical Modified mannitol for pharmaceutical tablets
US3384546A (en) * 1965-05-28 1968-05-21 Miles Lab Directly compressed low-density crystalline sorbitol pharmaceutical tablets
US3721725A (en) * 1970-08-14 1973-03-20 Du Pont Process for preparing powder blends
GB1548022A (en) * 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
IE53696B1 (en) * 1981-12-02 1989-01-18 Wyeth John & Brother Ltd Solid shaped articles
DE3275121D1 (en) * 1981-12-11 1987-02-19 Wyeth John & Brother Ltd Process for preparing solid shaped articles
US4698264A (en) * 1982-08-02 1987-10-06 Durkee Industrial Foods, Corp. Particulate composition and process for making same
US4695463A (en) * 1985-05-24 1987-09-22 Warner-Lambert Company Delivery system for active ingredients and preparation thereof
EP0272265B1 (de) * 1985-09-25 1991-05-22 Gergely, Gerhard, Dr. Zerfallstablette und verfahren zu ihrer herstellung
SE8601624D0 (sv) * 1986-04-11 1986-04-11 Haessle Ab New pharmaceutical preparations
GB8624628D0 (en) * 1986-10-14 1986-11-19 Scras Soluble/splitable tablets
US4760093A (en) * 1986-10-21 1988-07-26 American Home Products Corporation (Del.) Spray dried acetaminophen
US4771077A (en) * 1986-10-21 1988-09-13 American Home Products Corporation (Del.) Spray dried acetaminophen
US4760094A (en) * 1986-10-21 1988-07-26 American Home Products Corporation (Del.) Spray dried acetaminophen
US4767789A (en) * 1986-10-21 1988-08-30 American Home Products Corporation (Del.) Spray dried acetaminophen
US4835187A (en) * 1987-06-15 1989-05-30 American Home Products Corporation Spray dried ibuprofen
US4835186A (en) * 1987-06-15 1989-05-30 American Home Products Corporation Spray dried ibuprofen
US4915948A (en) * 1987-08-31 1990-04-10 Warner-Lambert Company Tablets having improved bioadhesion to mucous membranes
US4835188A (en) * 1987-12-08 1989-05-30 American Home Products Corporation Spray dried ibuprofen

Also Published As

Publication number Publication date
MX21218A (es) 1993-10-01
EP0404490B1 (de) 1993-07-14
DE69002198T2 (de) 1993-10-21
IE902216A1 (en) 1991-01-16
IE902216L (en) 1990-12-20
ES2057409T3 (es) 1994-10-16
CA2019228A1 (en) 1990-12-20
PT94395B (pt) 1997-01-31
IE63834B1 (en) 1995-06-14
EP0404490A1 (de) 1990-12-27
US4946684A (en) 1990-08-07
PT94395A (pt) 1991-02-08
DE69002198D1 (de) 1993-08-19
DK0404490T3 (da) 1993-08-23

Similar Documents

Publication Publication Date Title
ATE91409T1 (de) Schnelloesliche dosierungsformen.
FI920956A0 (fi) Doseringsform foer administrering av oral hypoglykemisk glipisid.
DK0600079T3 (da) Oral 1alpha-hydroxyprævitamin D
ES2040232T3 (es) Preparaciones medicinales para administracion oral conteniendo una sola dosis de 10 a 240 mg de dihidropiridina.
IT7849462A0 (it) Corpo di capsula in particolare per una capsula per la somministrazione di sostanze medicamentose come pure procedimento e dispositivo per lasua produzione
NO874960L (no) Flytende doseringsform for oral administrasjon av et farmasoeytisk aktivt stoff.
IT1225494B (it) Apparecchiatura per prevenire la formazione e curare le piaghe da decubito in pazienti lungodegenti
ES2062353T3 (es) Formulado farmaceutico.
DE3789239D1 (de) Pharmazeutische Zusammensetzung enthaltend Interferon für bukkale Verabreichung.
PT84416A (en) Process for the preparation of dosage forms having a regular and sustained release for oral administration containing polysaccharides of natural origin
ES536513A0 (es) Un dispositivo de suministro y mantenimiento de agente terapeutico para suministrar un nivel farmacologicamente eficaz de agente terapeutico al sitio de una infeccion periodontal.
RU93051537A (ru) Перорально вводимая лекарственная форма
AR012417A1 (es) COMPOSICIoN FARMACÉUTICA DE ADMINISTRACIoN ORAL Y PROCEDIMIENTO PARA SU PRODUCCION.
IT1235153B (it) Uso dell'acetil l-carnitina nel trattamento terapeutico della cataratta e composizioni farmaceutiche utili in tale trattamento
ATE60713T1 (de) Pharmazeutische zusammensetzung aus guar-gummi und anderen antiacida zum schutz der oeso-gastro- duodenalen schleimhaut.
DK160550C (da) Tetrahydroisoquinolin-2-ylderivater af carboxylsyrer som thromboxan-a2-antagonister, deres anvendelse i et medicinsk praeparat og farmaceutisk middel indeholdende dem
GR1000419B (el) Μορφη δοσολογιας για χορηγηση ανταγωνιστη του ασβεστιου.
SE9402157L (sv) Framaceutisk komposition med analgetisk aktivitet
KR890006227A (ko) 페놀-함유 진해성 액체 조성물
MY101916A (en) Etoposide oral dosage form.
FR2616327B3 (fr) Melange de plantes medicinales a titre de medicament pour le traitement des ulceres et des gastrites chroniques
KR890015746A (ko) 메게스트롤 아세테이트로 aids 악액질을 치료하는 방법
IT8548306A0 (it) Composizione per la preparazione di un medicamento da usare per la cura della piorrea alveolare
KR910015299A (ko) 우울증 치료방법
FR2635439B1 (fr) Preparation d'un desinfectant propre a prevenir la mammite subclinique chez les ruminants

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee